Dermatological adverse events associated with use of oral mechanistic target of rapamycin inhibitors in a cohort of individuals with tuberous sclerosis complex.
作者信息
Pithadia D J, Treichel A M, Jones A M, Julien-Williams P, Machado T, Moss J, Darling T N
机构信息
Department of Dermatology, Uniformed Services University, Bethesda, MD, USA.
Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
出版信息
Br J Dermatol. 2020 Sep;183(3):588-589. doi: 10.1111/bjd.19124. Epub 2020 May 26.
Abstract
摘要
相似文献
1
Dermatological adverse events associated with use of oral mechanistic target of rapamycin inhibitors in a cohort of individuals with tuberous sclerosis complex.
Br J Dermatol. 2020 Sep;183(3):588-589. doi: 10.1111/bjd.19124. Epub 2020 May 26.
2
Cannabidiol Elevates Mechanistic Target of Rapamycin Inhibitor Levels in Patients With Tuberous Sclerosis Complex.
Pediatr Neurol. 2020 Apr;105:59-61. doi: 10.1016/j.pediatrneurol.2019.11.017. Epub 2019 Dec 9.
3
Rapamycin reverses impaired social interaction in mouse models of tuberous sclerosis complex.
Nat Commun. 2012;3:1292. doi: 10.1038/ncomms2295.
4
Safety considerations of mammalian target of rapamycin inhibitors in tuberous sclerosis complex and renal transplantation.
J Clin Pharmacol. 2015 Apr;55(4):368-76. doi: 10.1002/jcph.428. Epub 2014 Dec 30.
5
Sirolimus for epilepsy in children with tuberous sclerosis complex: A randomized controlled trial.
Neurology. 2016 Sep 6;87(10):1011-8. doi: 10.1212/WNL.0000000000003077. Epub 2016 Aug 10.
6
Mechanistic target of rapamycin (mTOR) in tuberous sclerosis complex-associated epilepsy.
Pediatr Neurol. 2015 Mar;52(3):281-9. doi: 10.1016/j.pediatrneurol.2014.10.028. Epub 2014 Nov 20.
7
Management of side effects of mTOR inhibitors in tuberous sclerosis patients.
Pharmacol Rep. 2016 Jun;68(3):536-42. doi: 10.1016/j.pharep.2016.01.005. Epub 2016 Jan 22.
8
The differential effects of prenatal and/or postnatal rapamycin on neurodevelopmental defects and cognition in a neuroglial mouse model of tuberous sclerosis complex.
Hum Mol Genet. 2012 Jul 15;21(14):3226-36. doi: 10.1093/hmg/dds156. Epub 2012 Apr 24.
9
Mammalian target of rapamycin inhibitors in a patient with polycystic kidney disease-1-tuberous sclerosis-2 contiguous gene syndrome.
Saudi J Kidney Dis Transpl. 2018 Nov-Dec;29(6):1475-1479. doi: 10.4103/1319-2442.248317.
10
Rapamycin and rapalogs for tuberous sclerosis complex.
Cochrane Database Syst Rev. 2016 Jul 13;7(7):CD011272. doi: 10.1002/14651858.CD011272.pub2.
本文引用的文献
1
mTOR inhibitor therapy as a disease modifying therapy for tuberous sclerosis complex.
Am J Med Genet C Semin Med Genet. 2018 Sep;178(3):365-373. doi: 10.1002/ajmg.c.31655. Epub 2018 Oct 11.
2
Stomatitis associated with mammalian target of rapamycin inhibition: A review of pathogenesis, prevention, treatment, and clinical implications for oral practice in metastatic breast cancer.
J Am Dent Assoc. 2018 Apr;149(4):291-298. doi: 10.1016/j.adaj.2017.10.024. Epub 2018 Feb 10.
3
Everolimus long-term use in patients with tuberous sclerosis complex: Four-year update of the EXIST-2 study.
PLoS One. 2017 Aug 9;12(8):e0180939. doi: 10.1371/journal.pone.0180939. eCollection 2017.
4
Trichomegaly and scalp hair changes following treatment with erlotinib in pulmonary adenocarcinoma patients: A case report and literature review.
Exp Ther Med. 2016 Sep;12(3):1287-1292. doi: 10.3892/etm.2016.3460. Epub 2016 Jun 16.
5
Acneiform Rash Induced by EGFR Inhibitors: Review of the Literature and New Insights.
Skin Appendage Disord. 2015 Mar;1(1):31-7. doi: 10.1159/000371821. Epub 2015 Feb 13.
6
mTOR signaling promotes stem cell activation via counterbalancing BMP-mediated suppression during hair regeneration.
J Mol Cell Biol. 2015 Feb;7(1):62-72. doi: 10.1093/jmcb/mjv005. Epub 2015 Jan 20.
7
Mammalian target of rapamycin inhibitor-associated stomatitis.
Future Oncol. 2013 Dec;9(12):1883-92. doi: 10.2217/fon.13.141.
8
Acne in recipients of renal transplantation treated with sirolimus: clinical, microbiologic, histologic, therapeutic, and pathogenic aspects.
J Am Acad Dermatol. 2006 Jul;55(1):139-42. doi: 10.1016/j.jaad.2005.11.1072.
Zotero 插件